![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
Sponsors and Collaborators: |
Group Health Centre Ontario Ministry of Health and Long Term Care Hamilton Health Sciences Cardiac Rehabilitation in the Community Sault Area Hospital |
---|---|
Information provided by: | Group Health Centre |
ClinicalTrials.gov Identifier: | NCT00236210 |
VIP is a demonstration project with a goal to decrease modifiable risk factors for those with a higher risk of having a vascular event such as a heart attack or stroke or of developing vascular disease. Introduced as a study, VIP compares whether there is a significant reduction of modifiable vascular risk factors amongst patients who are intricately involved in a personalized directed program versus those being provided standard care by their physician. Low risk participants will be reviewed at the end of the study. Health care providers work collaboratively with the ‘VIP Team’ to improve the participant’s vascular health.
Condition | Intervention |
---|---|
Vascular Disease Diabetes Hypertension Hyperlipidemia Obesity |
Behavioral: Action Score goals |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study |
Official Title: | The Vascular Intervention Program (VIP) -- A Sault Ste. Marie Community Demonstration Project From the Group Health Centre Health Promotion Initiative Program |
Enrollment: | 645 |
Study Start Date: | August 2004 |
Study Completion Date: | July 2006 |
This Northern Ontario, community-based demonstration project is a multi-disciplinary, primary care provider-based collaboration. The goals of the project are to:
The Group Health Centre, a multi-disciplinary, not-for-profit community-based health organization with 56,000 rostered patients, leads the project.
However, all Sault Ste Marie community patients are eligible to join the Vascular Intervention Program (VIP). This program has three key components: a registry of VIP patients with audit, recall and feedback; use of the novel ACTION score template, and the optional use of VIPNet, a personalized patient record tool that provides secure web access to optimize quality and continuity of care. The VIP project aims to empower patients and increase collaboration among the primary health care team. Patients with any vascular risk factors will be eligible for VIP.
The VIP project is a demonstration project that does not duplicate existing GHC chronic disease management programs because (1) the VIP is offered to all eligible community patients, not only GHC enrollees; (2) VIP integrates any patients with vascular risk, not just those with pre-defined conditions; (3) novel collaborative tools such as the ACTION template and VIPNet website are being piloted; and (4) explicit patient-centred decision making drives the process. The development and evaluation of the VIP demonstration project is a unique step in the evolution of primary care chronic disease management in Sault Ste Marie, and the rest of the province.
Ages Eligible for Study: | 30 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Canada, Ontario | |
Group Health Centre | |
Sault Ste. Marie, Ontario, Canada, P6B 1Y7 |
Principal Investigator: | David Crookston, MD CCFP | Algoma District Medical Group and Group Health Centre |
Study ID Numbers: | Go3-03031 |
Study First Received: | October 7, 2005 |
Last Updated: | July 9, 2007 |
ClinicalTrials.gov Identifier: | NCT00236210 History of Changes |
Health Authority: | Canada: Health Canada |
Vascular Intervention Program Vascular Disease Coronary Artery Disease |
Diabetes Lifestyle Modification Modifiable Risk Factors |
Obesity Hyperlipidemias Metabolic Diseases Vascular Diseases Diabetes Mellitus Overweight Body Weight Coronary Disease |
Signs and Symptoms Nutrition Disorders Overnutrition Metabolic Disorder Coronary Artery Disease Dyslipidemias Hypertension Lipid Metabolism Disorders |
Obesity Hyperlipidemias Metabolic Diseases Vascular Diseases Overweight Body Weight Signs and Symptoms |
Nutrition Disorders Cardiovascular Diseases Overnutrition Dyslipidemias Hypertension Lipid Metabolism Disorders |